T44.1X5 Categoría · se requiere mayor especificidad Adverse effect of other parasympathomimetics [cholinergics]
ICD-10-CM T44.1X5 identifies “Adverse effect of other parasympathomimetics [cholinergics]” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Capítulo 19: Injury, poisoning and certain other consequences of external causes
Instrucciones del código
Sin notas adicionales.
Instrucciones de niveles superiores
Capítulos 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T44 · Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system
Seventh character1
The appropriate 7th character is to be added to each code from category T44
A — initial encounter
D — subsequent encounter
S — sequela
Códigos más específicos
T44.1X5AAdverse effect of other parasympathomimetics [cholinergics], initial encounterCódigo facturable y específicoT44.1X5DAdverse effect of other parasympathomimetics [cholinergics], subsequent encounterCódigo facturable y específicoT44.1X5SAdverse effect of other parasympathomimetics [cholinergics], sequelaCódigo facturable y específicoReferencias del índice oficial
Referencias del índice oficial (16)
Aceclidine (1)
- AceclidineFármacos y sustancias químicas
Acetylcholine (2)
- Acetylcholine › chlorideFármacos y sustancias químicas
- Acetylcholine › derivativeFármacos y sustancias químicas
Arecoline (1)
- ArecolineFármacos y sustancias químicas
Benzpyrinium bromide (1)
- Benzpyrinium bromideFármacos y sustancias químicas
Bethanechol (2)
- BethanecholFármacos y sustancias químicas
- Bethanechol › chlorideFármacos y sustancias químicas
Carbachol (1)
- CarbacholFármacos y sustancias químicas
Carbamylcholine chloride (1)
- Carbamylcholine chlorideFármacos y sustancias químicas
Cholinergic(drug) NEC (3)
- Cholinergic(drug) NECFármacos y sustancias químicas
- Cholinergic(drug) NEC › muscle tone enhancerFármacos y sustancias químicas
- Cholinergic(drug) NEC › trimethyl ammonium propanediolFármacos y sustancias químicas
Methacholine (1)
- MethacholineFármacos y sustancias químicas
Parasympathomimetic drug NEC (1)
- Parasympathomimetic drug NECFármacos y sustancias químicas
Pilocarpine (1)
- PilocarpineFármacos y sustancias químicas
Pilocarpus(jaborandi) extract (1)
- Pilocarpus(jaborandi) extractFármacos y sustancias químicas
Historial
Historial del código
Último cambio registrado · FY2025 · 04-01
Vigente desde
- Cambios en instrucciones heredadas
Adverse effect of other parasympathomimetics [cholinergics]
Categoría — seleccione un código más específico
CDC/NCHS · FY2025 · 04-01Todas las ediciones (19)
| Todas las ediciones | Vigente desde | Historial del código |
|---|---|---|
| FY2016 | 2015-10-01 | Primera aparición |
| FY2017 | 2016-10-01 | Sin cambios tabulares |
| FY2018 | 2017-10-01 | Sin cambios tabulares |
| FY2019 | 2018-10-01 | Cambios en instrucciones heredadas |
| FY2020 | 2019-10-01 | Sin cambios tabulares |
| FY2020 · April | 2020-04-01 | Sin cambios tabulares |
| FY2021 | 2020-10-01 | Cambios en instrucciones heredadas |
| FY2021 · 01-01 | 2021-01-01 | Sin cambios tabulares |
| FY2022 | 2021-10-01 | Sin cambios tabulares |
| FY2022 · 04-01 | 2022-04-01 | Sin cambios tabulares |
| FY2023 | 2022-10-01 | Sin cambios tabulares |
| FY2023 · 04-01 | 2023-04-01 | Sin cambios tabulares |
| FY2024 | 2023-10-01 | Sin cambios tabulares |
| FY2024 · 04-01 | 2024-04-01 | Sin cambios tabulares |
| FY2025 | 2024-10-01 | Sin cambios tabulares |
| FY2025 · 04-01 | 2025-04-01 | Cambios en instrucciones heredadas |
| FY2026 | 2025-10-01 | Sin cambios tabulares |
| FY2026 · April | 2026-04-01 | Sin cambios tabulares |
| FY2027 | 2026-10-01 | Sin cambios tabulares |
Explora los códigos más específicos de esta categoría. La comprobación del catálogo no establece la pertinencia clínica ni garantiza el reembolso.